Secretoneurin as a novel predictor of metabolic syndrome in patients with obstructive sleep apnea syndrome

İbrahim Arslan, Yasin Aslan, Muzaffer Arı, Hamit Yaşar Ellidağ, Ömer Tarık Selçuk · 2026

Read Secretoneurin as a novel predictor of metabolic syndrome in patients with obstructive sleep apnea syndrome by İbrahim Arslan, Yasin Aslan, Muzaffer Arı, Hamit Yaşar Ellidağ, Ömer Tarık Selçuk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13285276.txt.

Description

İbrahim Arslan and co-authors study secretoneurin as a possible marker of metabolic syndrome in sleep apnea patients in a 2026 article. Blocked breathing in sleep raises risk of weight gain, diabetes, high blood pressure, and heart disease, and metabolic syndrome is far more common in these patients than in the wider public. Secretoneurin is a small protein released by nerve and hormone cells under low oxygen stress.

The authors frame secretoneurin as a candidate early signal, since it rises with hypoxia and links to inflammation and vessel action. Its level tracks with blood triglyceride levels in the work highlighted here. They argue a simple blood marker could help flag apnea patients who are moving toward metabolic syndrome.

Catalog record

CREATORİbrahim Arslan, Yasin Aslan, Muzaffer Arı, Hamit Yaşar Ellidağ, Ömer Tarık Selçuk
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31885
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13285276

Browse the full library · About the Tower of Babel